Skip to main content
C

ChyloCure

ChyloCure develops ChyloRelief™ products utilizing Chylobinoid®, a magnesium-infused, full-spectrum cannabinoid complex that enhances bioavailability and absorption compared to traditional hemp-derived products. These formulations address pain from inflammation and support the endocannabinoid system, providing both internal and external relief options.

Founded 2020410+ followers
Updated 4 months ago

Funding

$150K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional hemp-derived cannabinoid products often suffer from poor absorption and limited bioavailability, reducing their effectiveness in addressing pain and supporting the endocannabinoid system. This can lead to inconsistent results and the need for higher dosages to achieve the desired therapeutic effects.

Solution

ChyloCure develops ChyloRelief™ products powered by Chylobinoid®, a proprietary magnesium-infused, full-spectrum cannabinoid complex designed for enhanced bioavailability and absorption compared to standard hemp-derived products. The ChyloRelief™ line includes both topical and internal formulations that leverage all-natural ingredients to target pain from inflammation and support the body's endocannabinoid system. Chylobinoid's enhanced absorption aims to deliver more consistent and potent effects, providing users with a more reliable and effective solution for managing pain and promoting overall wellness. The company's cGMP certified facility ensures product quality and consistency.

Target Audience

The primary target audience includes consumers seeking natural relief from pain and inflammation, as well as individuals looking to support their endocannabinoid system with enhanced cannabinoid bioavailability. ChyloCure also targets businesses interested in offering cannabinoid products to their customers.

Features

  • Chylobinoid®: A magnesium-infused, full-spectrum cannabinoid complex for enhanced absorption.
  • Topical formulations: Designed for external use to relieve pain due to inflammation, dry skin, and irritation.
  • Capsule formulations: Designed for internal use to support the body’s endocannabinoid system.
  • Full-spectrum cannabinoid complex: Contains a range of cannabinoids and cannabidiolic acid (CBDa).
  • All-natural ingredients: Products are formulated with natural ingredients.
  • cGMP certified production: ChyloCure’s facility is certified by the Virginia Department of Agriculture and Consumer Services (VDACS) Food Safety Program.
This profile is AI-generated and may contain inaccuracies.